Obestatin inhibits proliferation and differentiation of 3T3-L1 preadipocytes

Academic Journal of Second Military Medical University

Volumn 28, Issue 9, 2007, Pages 929-932

  Zhang, Zheng ^a   Zou, Da Jin ^a   Chen, Yue ^a   Wang, Miao ^a   Wu, Jie ^a   Guo, Zhi Fu ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

3T3 L1 preadipocyte; Cell differentiation; Cell proliferation; Ghrelin; Obestatin; PPAR 2 gene

Indexed keywords

FAT DROPLET; GHRELIN; LIPID; MESSENGER RNA; OBESTATIN; PEPTIDE HORMONE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA 2; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL STRAIN 3T3; CONTROLLED STUDY; GENE EXPRESSION; HORMONE ACTION; INHIBITION KINETICS; LIPID STORAGE; NONHUMAN; PROADIPOCYTE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STAINING;

EID: 34848914833     PISSN: 0258879X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Zhang J V, Ren P G, Avsian-Kretchmer O, et al. Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin' s effects on food intake[J]. Science, 2005, 310: 996-999.
2. Vivenza D, Rapa A, Castellino N, et al. Ghrelin gene poly-morphisms and ghrelin, insulin, IGF-1, leptin and anthropometric data in children and adolescents[J]. Eur J Endocrinol, 2004, 151: 127-133.
3. Szentirmai E, Krueger J M. Obestatin alters sleep in rats[J]. Neurosci Lett, 2006, 404: 222-226.
4. Szentirmai E, Haidu I, Obal F Jr, et al. Ghrelin-induced sleep responses in ad libitum fed and food-restricted rats[J]. Brain Res, 2006, 1088: 131-140.
5. Kim M S, Ycon C Y, Jang P G, et al. The mitogenic and anti-apoptotic actions of ghrelin in 3T3-L1 adipocytes[J]. Mol Endocrinol, 2004, 18: 2291-2301.
6. Chinese source.
7. Gregoire F M, Smas C M, Sul H S. Understanding adipocyte differentiation[J]. Physiol Rev, 1998, 78: 783-809.
8. Catalan V, Gomez-Ambrosi J, Rotellar F, et al. The obestatin receptor (GPR39) is expressed in human adipose tissue and is down-regulated in obesity-associated type 2 diabetes mellitus [J]. Clin Endocrinol, 2007, 66: 598-601.